Enzymatic bioassay for therapeutic drug monitoring of HIV protease inhibitors

被引：0
|
作者：
Gulnik, S
Yu, B
Markowitz, M
Erickson, JW
机构：
[1] Sequoia Pharmaceut, Frederick, MD USA
[2] Aaron Diamond AIDS Res Ctr, New York, NY USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
94
引用
收藏
页码：S103 / S103
页数：1
相关论文
共 50 条
  • [1] Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance
    Hugen, PWH
    Burger, DM
    Aarnoutse, RE
    Baede, PA
    Nieuwkerk, PT
    Koopmans, PP
    Hekster, YA
    THERAPEUTIC DRUG MONITORING, 2002, 24 (05) : 579 - 587
  • [2] Role of therapeutic drug monitoring for protease inhibitors
    John, L
    Marra, F
    Ensom, MHH
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (06) : 745 - 754
  • [3] Therapeutic drug monitoring in HIV-infected pregnant women with a focus on protease inhibitors
    Waqas, Sarmad
    Lambert, John S.
    FUTURE VIROLOGY, 2015, 10 (07) : 915 - 922
  • [4] Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors
    Beauverie, P
    Taburet, AM
    Dessalles, MC
    Furlan, V
    Touzeau, D
    AIDS, 1998, 12 (18) : 2510 - 2511
  • [5] Can saliva be used for therapeutic drug monitoring of protease inhibitors in HIV-infected children?
    Rakhmanina, NY
    van den Anker, JN
    Sever, J
    Spiegel, H
    Soldin, SL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P73 - P73
  • [6] An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancy
    Angel, JB
    Khaliq, Y
    Monpetit, ML
    Cameron, DW
    Gallicano, K
    AIDS, 2001, 15 (03) : 417 - 419
  • [7] Routine therapeutic drug monitoring in patients on protease inhibitors: Impact on therapeutic decisions?
    Aries, SP
    Schaaf, BM
    Wilmsen, U
    Schuett, M
    Kurowski, M
    AIDS, 2000, 14 : S91 - S92
  • [8] Therapeutic drug monitoring for the protease inhibitors in HIV patients undergoing first triple therapy regimen.
    Aziz, D
    Bean, P
    Graziano, FM
    CLINICAL CHEMISTRY, 1999, 45 (06) : A65 - A65
  • [9] Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice
    Cleijsen, R. M. M.
    De Ende, M. E. Van
    Kroon, F. P.
    Lunel, F. Verduyn
    Koopmans, P. P.
    Gras, L.
    De Wolf, F.
    Burger, D. M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (04) : 897 - 900
  • [10] Therapeutic drug monitoring of protease inhibitors during long-term treatment of HIV-infected patients
    Kurowski, M
    Arasteh, K
    Möcklinghoff, C
    Müller, M
    AIDS, 1998, 12 : S31 - S31
12345